Screener
Cardiol Therapeutics CRDL Q1 2026 earnings
Reported May 11, 2026 · After market close
EPS-$0.07In line
EPS estimate-$0.07
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did Cardiol Therapeutics report Q1 2026 earnings?
- Cardiol Therapeutics (CRDL) reported Q1 2026 earnings on May 11, 2026 after market close.
- What were Cardiol Therapeutics's Q1 2026 revenue and EPS?
- Cardiol Therapeutics reported eps of $-0.07 for Q1 2026.
- Did Cardiol Therapeutics beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.07 by $0.00.
- How did Cardiol Therapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 30.0% from $-0.10.
